"The Li family was lucky, and I survived this time." Hu Chi disappeared for a few days, and when he reappeared, he looked like a survivor.

Yang Rui wanted to laugh when he heard it, soaking tea slowly, and said: "The winter of the old chronic disease patients is the most difficult, but as long as it passes, it will continue for another year."

"Yes, the coldest time has passed, and there should be no more changes next." Hu Chi drank the tea, praised, and said: "Can't the cost of making medicine be lowered? This year is past and there is next year."

After Mr. Li, there is also Mr. Wang. If this is the case, Comrade Hu Chi naturally does not need to say it.

Yang Rui said indifferently: "It's okay, there are expensive methods, and the poor have poor methods."

He is not perfunctory. Regardless of the fact that there is no new drug development in China, on the one hand, there is a huge risk, on the other hand, the regulations are relatively backward and there is no motivation to develop new drugs.

After all, most companies have to deal with the local market and the domestic market.

For Chinese companies, the primary goal of R&D is to solve the problem of domestic drug use. However, domestic medical policies are far less complex and demanding than those of Europe and the United States.

For the same clinical trials, all steps can be basically eliminated in China. Traditional Chinese medicines and proprietary Chinese medicines do not even need to be double-blind, and any clinical trials are needed.

In this context, domestic companies mainly have no experience in developing new drugs, which has resulted in a situation where no new drug has appeared.

In contrast, Yang Rui, who has done iron ketones in the past, has more experience in the development of new drugs.

If necessary, he can guide the researchers to develop new drugs without having to do it himself.

No matter how small the funds are, it is not impossible to develop new drugs with second-hand equipment and low-end equipment.

It's nothing more than a longer time, the success rate is the first point.

If you don't want to waste the time of the researchers in the ion channel laboratory, Yang Rui can even hire temporary employees.

Hu Chi is now familiar with Yang Rui's speaking pattern, but he is very alert and asks: "How poor?"

"Poor way." Yang Rui groaned for a moment, and said: "Sixty to seven million dollars should be prepared. If it is less, it will reach 50 million dollars. If it is less, it will be useless to do the wrong two directions. When the time comes, it will be wasted."

Yang Rui was not deliberately alarmist. Even if he can see the direction clearly, he doesn't know how long the experiment will take.

Hu Chi curled his lips while listening, and said, "Who can get fifty million at this time. It's still US dollars."

Yang Rui shrugged and said: "I am going to iron ketone to achieve the second phase of the clinical trial. If you are willing to hand over the latter part to a foreign company, you can do it for another 30 million US dollars. This is the same as the Gaucher disease I am doing now. The cost of the medicine is almost the same. Of course, it is possible that glucocerebrosidase cannot be made at $30 million, but if something is made and hope is shown, Zeleca should still be willing to increase the cost."

"We don't have the money to add additional costs."

"we?"

Hu Chi coughed twice and said, "Master Li, it is also the old revolution of the year. In short, 30 million US dollars is still too much."

"Then there is no way, this is the price of fine and poor."

"Can you talk to Zelecom? Let them join in and work together?" Hu Chi obviously did his homework. What he wanted was nothing more than a new drug. Although everyone didn't even talk about the new drug, he always subconsciously felt that the new drug would be good.

From this perspective, the introduction of foreign companies seems to be irrelevant. Not only saved the initial investment funds, but also got the medicines I wanted. The so-called market for technology is also.

However, medicines for common chronic diseases are not areas that are easy to capture like rare diseases.

Even multinational companies such as Zeleca must be cautious in this field. In history, there have been more than one related cases of investing 500 million US dollars in the quagmire.

There are more than one or two Nobel Prize winners fighting in this field.

Yang Rui smiled and said, "You can try it with Zelican. Before the glucocerebrosidase substitute enzyme is on the market, they may not be able to dedicate their energy to a more complex drug."

Hu Chi had no aura, and said: "You can't even talk about it, let alone let us talk about it."

However, Hu Chi did not give up completely. He drank two sips of tea, and said, "Isn’t the project you are doing now put together a little bit? After two years, let the old Li family get you some more, not necessarily. Suffer."

Yang Rui smiled and said, "Kan Minger waits for you to see the prices of equipment, so you won't say that."

He was talking about the upcoming procurement delegation.

"Okay..." Hu Chi has no say in the professional field, but as far as his experience is concerned, foreigners' equipment is indeed outrageously expensive.

However, neither Yang Rui nor Hu Chi expected what kind of agitation would be caused after the news of the procurement delegation spread.

For the Nobel Prize, it is not a trivial matter for the industry to organize a delegation to go abroad for procurement.

There was a need for replacement and purchase of materials. Needless to say, central enterprises and large state-owned enterprises that had no plans have also begun to rush to find a relationship.

When Yang Rui went home, he was only at the entrance of the alley when he was stopped by a few state-owned enterprise leaders who worked privately with microservices.

It is very difficult to hide your address in the country. Unless it is a small person who is not concerned, there will always be a day of leakage.

Yang Rui had a banquet in the house, and he had expected it, but the former officials liked to stop at the door of the laboratory, but it was rare to stop at the door of the house.

"Director Yang."

"Professor Yang..."

Several state-owned enterprise leaders greeted each other, but they were not in the same group.

Yang Rui really wanted to shoot a startle, and asked "what's the matter?"

"Professor Yang, I heard that you are going to organize a purchasing delegation to go to Europe to do sourcing?" An official took the initiative to express his intentions. He stood too far behind, chatting away.

Yang Rui nodded and said: "There is such a thing, but it is not my organization. It should be the Chemical Drug Promotion Office or other organizations taking the lead."

"No matter which department it is, you must have the final say." The official smiled a compliment, and said: "Professor Yang, our Siyou Company is a medical machinery manufacturing company directly under the ministry and has long been thinking about it. It's time to update the production line. Look, can you join your delegation this time."

"It's useless for you to find me..."

"You don't need a quota for the delegation, we'll just follow, you can just take the time to give a suggestion~lightnovelpub.net~please please." After this, he stuffed a business card into Yang Rui's hand and put another one. Wrapped gifts on the ground, turned around and left.

Others saw it, got it, just do it, anyway, everyone has no friendship, then speak in sincerity.

After a while, a gift ticket encircled Yang Rui into a circle, and his hand was also full of business cards.

"Wait, wait." Yang Rui grabbed the smaller individual and said: "Don't want a delegation, what does it mean to follow?"

Seeing that Yang Rui was really unaware of the small size of the leader, he said naturally: "There must be a small number of delegations, and we do not expect to get it. We will bring our own money to buy tickets and follow you. At that time, if you can Thank you very much for a few pointers."

Yang Rui thought about it for a while before he realized that the number of delegations was mostly controlled by Hu Chi. The activities organized by the Chemical Drug Promotion Office were also the money paid by the Chemical Drug Promotion Office, and they naturally took the big head.

If it is a large enterprise such as a centrally-owned enterprise, the leaders are probably going to public relations at Hu Chi. Those who come to Yang Rui want to wipe it out.

To say that Chinese companies are also pitiful. They don’t know the language. They have poor understanding of the world trading system, and they don’t know much about professional knowledge.

In an era when many companies did not have college graduates, it was quite possible to say that the employees of the company could know the status of the latest equipment and equipment. Even through some institutions such as foreign affairs newspapers and research institutes, it is difficult to understand them comprehensively.

Of course, in more cases, various research institutes simply don't bother to care about such enterprises.

To be able to act with the Nobel Prize winners is obviously an economic choice for them.

However, the size of this delegation is difficult to control.

Yang Rui couldn't imagine how many domestic companies would have similar demands.